Triology Longevity, originated from Los Angles, USA, and is a global leader in the field of longevity and regenerative medicine, currently operating in Shanghai, China.
What we do
Triolgoy Longevity Institute. The Longevity Medicine Centers and Clinics
TRIOLOGY LONGEVITY MEDICAL, originating from Los Angeles, USA, is a global exemplar in the field of longevity and regenerative medicine. With cutting-edge science and technology, an international team of experts, and innovative medical concepts, TRIOLOGY LONGEVITY is committed to providing high-end, personalized health management and anti-aging solutions for global elites, pioneering a new era in longevity medicine.
As a leader in the longevity and regenerative medicine industry, TRIOLOGY LONGEVITY has taken the lead in combining induced pluripotent stem cell (iPSC) life reprogramming technology with gene therapy technology, advancing the practical application of cellular repair and regenerative medicine, achieving significant breakthroughs in reversing aging and extending health. Additionally, the group relies on world-class technical platforms and top-tier scientific research capabilities to build a comprehensive service system covering precise health assessment, aging intervention, disease prevention, and medical aesthetics, offering clients a full-spectrum longevity medical solution from "prevention" to "treatment."
Supported by a powerful team of Nobel laureates and world-leading scientists from Oxford, Harvard, Cambridge, and other prestigious institutions, TRIOLOGY LONGEVITY has become a leading brand in the global longevity and regenerative medicine field through continuous technological innovation and industrial practice. The group's high-end brand "Harborfront Medical" has successfully introduced the 7v1-6 dimensional longevity medical private healthcare system into the Chinese market, providing high-net-worth clients with precise and comprehensive health management services.
-
Standing at the frontier of the innovative technologies targeting the biggest problem of human being
-
Supported by long years of R&D and self-owned Ips
-
Co-working with the leading brains and world-class scientists in human longevity and futurology
-
Extending healthspan and empowering the business
-
Beyond the economic values of Multi-trillions $
-
Integrating and supported by multidisciplinary resources
Longevity Medicine - Longevity Technology - Longevity Industry
-Biotechnology, biomedicine, life and health, and related cutting-edge technologies have provided unprecedented opportunities for significantly extending human lifespan; The development and rise of longevity technology will bring fundamental and revolutionary changes to human social civilization and health
-Longevity Medicine: With the core goals of age reversal, health span extension, healthy aging, and health longevity growth, it leads the development model and trend of the medical and health industry in the 21st century
-Longevity medicine aims to slow down the aging process and extend a healthy lifespan (Kangshou). It is the ultimate export of preventive medicine, precision medicine, personalized medicine, regenerative medicine, advanced diagnosis and treatment, and even medical devices
-Longevity medicine, longevity industry, and the subsequent emergence of longevity economics have become significant and influential branches in the fields of medicine and social economics: extending the healthy lifespan of populations by just one year can contribute billions of dollars in wealth to society
-Longevity medicine, longevity industry, and the subsequent emergence of longevity economics have become significant and influential branches in the fields of medicine and social economics: extending the healthy lifespan of populations by just one year can contribute billions of dollars in wealth to society
-Longevity Medicine: With the direct goal of maintaining health, the focus of attention and intervention is placed on the health stage rather than old age or disease state. Biopharmaceuticals and life health technologies aimed at longevity medicine have become a major trend in international economic and industrial development. The Atros Lab, which raised $3 billion in angel investment from its start-up, has an annual investment of $1 billion. The Hevolution Foundation fund has emerged dozens of high-tech enterprises in anti-aging and longevity medicine with investments exceeding $100 million each year
-MIT Technology Review: If a company has technology or products that increase lifespan by 2 years, its valuation will exceed billions of dollars